Table 2.

Predicted effect of screening and time to diagnostic testing of screening abnormalities on lifetime cancer incidence per 100 screened.

		Change in Cancer Incidence with Screening
Model	Unscreened	Immediate Diagnosis	3 months	6months	12months
Breast	11.0	2.6  (24.0%)	2.6  (23.5%)	2.5  (22.9%)	2.4  (21.7%)
Cervical	2.2	−1.9 (−88.9%)	−1.9 (−87.6%)	−1.9 (−86.6%)	−1.8 (−84.8%)
CRC-SPIN	7.2	−5.3 (−73.9%)	−5.3 (−73.6%)	−5.3 (−73.3%)	−5.2 (−72.5%)
MISCAN-Colon	6.6	−3.1 (−46.9%)	−3.1 (−46.1%)	−3.0 (−45.4%)	−2.9 (−44.2%)